CIK 0001053369 · Non-accelerated filer<br>Smaller reporting company
ELITE PHARMACEUTICALS INC /NV/
Sign in to watch- Ticker
- ELTP
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 223542636
- Phone
- 2017502646
- Business address
- 165 LUDLOW AVENUE, NORTHVALE, NJ, 07647
- Former names
- ELITE PHARMACEUTICALS INC /DE/
- Open-market buys, last 90 days
- $34,590
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$34,590. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-02-26 | Dash Barry H Director | Grant or award | +161,374 | $0.12 | $20K | 1,415,831 |
| 2018-02-26 | Caskey Davis S Director | Grant or award | +161,374 | $0.12 | $20K | 229,892 |
| 2017-04-28 | Hakim Nasrat A CEO & President | Other disposition | −158,017,321 | 9,097,561 | ||
| 2017-04-28 | Hakim Nasrat A CEO & President | Other acquisition · Series J Convertible Preferred Shares | +24.03 | $1,000,000.00 | $24.0M | 24.03 |
| 2017-04-28 | Hakim Nasrat A CEO & President | Other acquisition · Warrants | +79,008,661 | 79,008,661 | ||
| 2017-02-23 | Pfeifer Eugene M Director | Grant or award | +72,040 | $0.20 | $15K | 72,040 |
| 2017-02-23 | Caskey Davis S Director | Grant or award | +68,518 | $0.20 | $13K | 68,518 |
| 2017-02-23 | Plassche Douglas SVP of Operations | Grant or award | +110,849 | $0.23 | $25K | 285,879 |
| 2017-02-23 | Ward Carter Julian Director | Grant or award | +133,019 | $0.23 | $30K | 1,885,304 |
| 2017-02-23 | WHITNELL JEFFREY A Director | Grant or award | +88,679 | $0.23 | $20K | 1,206,102 |
| 2017-02-23 | Dash Barry H Director | Grant or award | +88,679 | $0.23 | $20K | 1,254,457 |
| 2017-02-23 | Hakim Nasrat A CEO & President | Grant or award | +2,216,992 | $0.23 | $500K | 24,143,785 |
| 2016-08-17 | Hakim Nasrat A CEO & President | Option exercise | +142,857,143 | 142,971,097 | ||
| 2016-08-17 | Hakim Nasrat A CEO & President | Option exercise · Series I Convertible Preferred Shares | −100 | 0 | ||
| 2016-04-28 | Ward Carter Julian CFO, Secretary, Treasurer | Conversion | +666,667 | $0.06 | $42K | 1,752,285 |
| 2016-04-28 | Ward Carter Julian CFO, Secretary, Treasurer | Conversion · Warrants | −666,667 | 0 | ||
| 2016-04-13 | NARINE JEENARINE Former Director | Conversion | +4,000,000 | $0.06 | $250K | 16,742,395 |
| 2016-04-13 | NARINE JEENARINE Former Director | Conversion · Warrants | −333,333 | 0 | ||
| 2016-04-13 | NARINE JEENARINE Former Director | Conversion · Warrants | −2,424,333 | 0 | ||
| 2016-04-13 | NARINE JEENARINE Former Director | Conversion · Warrants | −1,242,334 | 2,935,986 |
Page 3 of 8 · 159 trades